Industrial Applications Of 2-Amino-Isonicotinic Acid In API Synthesis
- 2-Aminoisonicotinic acid (CAS 13362-28-2) serves as a critical bifunctional building block in neurological and anti-inflammatory API scaffolds.
- Advanced synthesis routes enable industrial-scale production with ≥97% purity and total yields up to 89.2%, supporting cost-efficient GMP manufacturing.
- NINGBO INNO PHARMCHEM CO.,LTD. offers bulk supply with full COA documentation, optimized for multi-step pharmaceutical synthesis workflows.
In modern active pharmaceutical ingredient (API) development, heterocyclic intermediates with dual functional handles are indispensable for constructing complex molecular architectures. Among these, 2-Aminoisonicotinic acid—also systematically named 2-aminopyridine-4-carboxylic acid or 2-amino-4-pyridinecarboxylic acid—has emerged as a high-value synthon due to its orthogonal reactivity profile. Its pyridine core, substituted with both an electron-donating amine at C2 and a carboxylic acid at C4, enables sequential derivatization critical for multi-step API synthesis, particularly in CNS-targeted therapeutics.
Role in Constructing Neurological Drug Scaffolds
The structural motif of 2-aminoisonicotinic acid is strategically embedded in several commercial and investigational APIs targeting neurological pathways. The amine group facilitates amide coupling or reductive amination, while the carboxylic acid allows esterification, amidation, or conversion to acyl chlorides—enabling rapid diversification. This bifunctionality is especially valuable in synthesizing gamma-aminobutyric acid (GABA) modulators, kinase inhibitors, and nicotinic receptor ligands.
For instance, in the synthesis of certain anxiolytics and antiepileptics, 2-aminoisonicotinic acid acts as the foundational scaffold upon which aryl or heteroaryl substituents are introduced via Pd-catalyzed cross-coupling. The electron-rich amine enhances regioselectivity during halogenation or metalation steps, reducing byproduct formation and improving overall reaction yield. When sourcing high-purity 2-Aminoisonicotinic Acid, buyers should prioritize suppliers who guarantee consistent industrial purity (>97%) and minimal heavy metal residues to ensure downstream process robustness.
Case Studies: Use in Multi-Step API Manufacturing
Recent process chemistry innovations have leveraged 2-aminoisonicotinic acid in streamlined API routes. One notable example involves its use in a three-step sequence to generate a key intermediate for a selective JAK2 inhibitor. Here, the carboxylic acid was first protected as a methyl ester, followed by Suzuki–Miyaura coupling at C5, and finally deprotection under mild basic conditions—achieving >85% isolated yield across the sequence.
Another application lies in the synthesis of antimicrobial agents where the molecule undergoes diazotization at the amine group, enabling Sandmeyer-type transformations to introduce cyano or halo functionalities. Such versatility underscores why manufacturers demand reliable access to this intermediate with batch-to-batch consistency. The synthesis route
This route exemplifies a cost-effective manufacturing process that avoids expensive catalysts or cryogenic conditions, making it ideal for industrial adoption. Key parameters include a 1:8 molar ratio of starting material to liquid ammonia, reaction at 65°C for 8 hours, followed by hydrolysis with 2 mol/L NaOH at 70°C for 4 hours. The resulting crude product requires only pH adjustment and solvent extraction—minimizing waste and energy consumption.
Regulatory and Impurity Profile Considerations for GMP Compliance
For API manufacturers operating under ICH Q7 and EU GMP guidelines, the impurity profile of starting materials like 2-aminoisonicotinic acid directly impacts regulatory filings. Residual solvents, inorganic salts (e.g., NaCl from neutralization), and trace metals must be controlled to parts-per-million levels. Reputable suppliers provide comprehensive Certificates of Analysis (COA) detailing assay, water content (KF), residual solvents (GC), and elemental impurities (ICP-MS).
NINGBO INNO PHARMCHEM CO.,LTD., as a premier global manufacturer, ensures its 2-aminoisonicotinic acid meets stringent pharmacopeial standards (EP/USP) and supports DMF submissions. Their quality system includes rigorous raw material qualification, in-process controls, and stability-indicating analytical methods. This commitment to quality enables seamless tech transfer and reduces validation burden for API developers.
Moreover, bulk procurement from such a vertically integrated supplier offers commercial advantages: competitive bulk price
Technical Comparison of Industrial-Grade 2-Aminoisonicotinic Acid
| Parameter | Specification | Analytical Method |
|---|---|---|
| CAS Number | 13362-28-2 | - |
| Chemical Name | 2-Amino-isonicotinic acid / 2-Aminopyridine-4-carboxylic acid | IUPAC |
| Assay (Purity) | ≥97.0% | HPLC (UV 254 nm) |
| Appearance | White to off-white crystalline powder | Visual |
| Water Content | ≤1.0% | Karl Fischer |
| Residual Solvents | Meets ICH Q3C limits | GC |
| Heavy Metals | ≤10 ppm | ICP-MS |
| Total Yield (Industrial Route) | Up to 89.2% | Mass balance |
In summary, 2-aminoisonicotinic acid is far more than a simple heterocyclic acid—it is a strategic enabler of efficient, scalable API synthesis. With its proven utility in neurological drug programs, robust industrial synthesis route, and stringent quality control, it remains a cornerstone intermediate for innovative pharmaceutical manufacturers. NINGBO INNO PHARMCHEM CO.,LTD. stands out as a trusted partner, delivering high-purity material with full technical support and global supply capability to meet the evolving demands of the life sciences industry.